# FDA drug recall: Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: 

> recall · VERIFIED · 2026-06-24

Firm: Reliance Life Sciences Private Limited · Class II · Lack of Sterility Assurance

- Company: Reliance Life Sciences Private Limited
- Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.